|3Jun 24, 6:22 PM ET

DELUCCIA ROBERT J 3

3 · Acurx Pharmaceuticals, Inc. · Filed Jun 24, 2021

Insider Transaction Report

Form 3
Period: 2021-06-24
DELUCCIA ROBERT J
Director10% Owner
Holdings
  • Common Stock

    1,026,427
  • Warrants for Common Stock

    Exercise: $2.00From: 2018-03-20Exp: 2028-03-20Common Stock (6,250 underlying)
  • Common Stock

    (indirect: By Spouse)
    3,847
  • Warrants for Common Stock

    Exercise: $3.00From: 2018-10-23Exp: 2028-10-23Common Stock (8,334 underlying)
  • Warrants for Common Stock

    Exercise: $4.00From: 2019-03-29Exp: 2029-03-29Common Stock (3,125 underlying)
  • Warrants for Common Stock

    Exercise: $4.00From: 2019-08-08Exp: 2029-08-08Common Stock (3,125 underlying)
  • Warrants for Common Stock

    Exercise: $4.00From: 2019-10-18Exp: 2029-10-18Common Stock (3,125 underlying)
Footnotes (1)
  • [F1]Reflects the conversion of membership interests to common stock pursuant to the corporate conversion of Acurx Pharmaceuticals, Inc.

Documents

2 files